Search

Gary B. Nickol

Supervisory Patent Examiner (ID: 17728, Phone: (571)272-0835 , Office: P/1645 )

Most Active Art Unit
1642
Art Unit(s)
OPT, 1643, 1642, 1646, 1645
Total Applications
533
Issued Applications
167
Pending Applications
180
Abandoned Applications
184
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 999678 [patent_doc_number] => 06911529 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-28 [patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/602362 [patent_app_country] => US [patent_app_date] => 2000-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7192 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911529.pdf [firstpage_image] =>[orig_patent_app_number] => 09602362 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/602362 		Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Jun 21, 2000 Issued
09/594577 Method for detection of carcinoembryonic antigens having a modified sugar chain structure Jun 14, 2000 Abandoned
09/509731 HUMAN FACILITATIVE GLUCOSE TRANSPORT PROTEIN GLUT8 Jun 8, 2000 Abandoned
09/589395 Apo-2L receptor agonist and CPT-11 synergism Jun 6, 2000 Abandoned
09/580803 Antagonists of neuropilin receptor function and use thereof May 29, 2000 Abandoned
Array ( [id] => 1142997 [patent_doc_number] => 06777534 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Peptide antagonists of vascular endothelial growth factor' [patent_app_type] => B1 [patent_app_number] => 09/579420 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 12069 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777534.pdf [firstpage_image] =>[orig_patent_app_number] => 09579420 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/579420 		Peptide antagonists of vascular endothelial growth factor May 24, 2000 Issued
60/266330 Method of regulating angiogenesis using Ryk protein May 9, 2000 Pending
Array ( [id] => 1407039 [patent_doc_number] => 06528247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Determining the transforming capability of agents' [patent_app_type] => B1 [patent_app_number] => 09/485551 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 9427 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528247.pdf [firstpage_image] =>[orig_patent_app_number] => 09485551 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/485551 		Determining the transforming capability of agents May 1, 2000 Issued
09/556440 Down-regulation of DNA repair to enhance sensitivity to P53-mediated suppression Apr 23, 2000 Abandoned
09/549721 USE OF ANTIOXIDANTS TO MITIGATE RADIOIMMUNOTHERAPY-INDUCED RADIATION TOXICITY Apr 13, 2000 Abandoned
09/091815 HUMAN CHD-1 LIKE GENE Apr 12, 2000 Abandoned
09/547938 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death Apr 10, 2000 Abandoned
Array ( [id] => 1413997 [patent_doc_number] => 06518012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Method for regulating the expression of MHC antigens and CD40 by inhibitors of histone deacetylation' [patent_app_type] => B1 [patent_app_number] => 09/540257 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 4978 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518012.pdf [firstpage_image] =>[orig_patent_app_number] => 09540257 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/540257 		Method for regulating the expression of MHC antigens and CD40 by inhibitors of histone deacetylation Mar 30, 2000 Issued
Array ( [id] => 6650859 [patent_doc_number] => 20030104977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'METHODS FOR INDUCING ANGIOGENESIS USING MORPHOGENIC PROTEINS AND STIMULATORY FACTORS' [patent_app_type] => new [patent_app_number] => 09/540466 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14711 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104977.pdf [firstpage_image] =>[orig_patent_app_number] => 09540466 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/540466 		METHODS FOR INDUCING ANGIOGENESIS USING MORPHOGENIC PROTEINS AND STIMULATORY FACTORS Mar 30, 2000 Abandoned
09/535597 Prostate cancer-specific marker Mar 26, 2000 Abandoned
Array ( [id] => 1176884 [patent_doc_number] => 06747133 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Antibodies against the tumor suppressor gene ING1' [patent_app_type] => B1 [patent_app_number] => 09/532868 [patent_app_country] => US [patent_app_date] => 2000-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 16500 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747133.pdf [firstpage_image] =>[orig_patent_app_number] => 09532868 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/532868 		Antibodies against the tumor suppressor gene ING1 Mar 21, 2000 Issued
Array ( [id] => 1329649 [patent_doc_number] => 06596276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Method for inhibiting tumor angiogenesis in a living subject' [patent_app_type] => B1 [patent_app_number] => 09/532310 [patent_app_country] => US [patent_app_date] => 2000-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 17498 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596276.pdf [firstpage_image] =>[orig_patent_app_number] => 09532310 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/532310 		Method for inhibiting tumor angiogenesis in a living subject Mar 21, 2000 Issued
09/526329 TCL-1b gene and protein and related methods and compositions Mar 14, 2000 Abandoned
09/508420 CORNEAL NEOVASCULARIZATION INHIBITORS Mar 12, 2000 Abandoned
Array ( [id] => 1517987 [patent_doc_number] => 06500942 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Rin2, a novel inhibitor of Ras-mediated signaling' [patent_app_type] => B1 [patent_app_number] => 09/522955 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 19884 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500942.pdf [firstpage_image] =>[orig_patent_app_number] => 09522955 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/522955 		Rin2, a novel inhibitor of Ras-mediated signaling Mar 9, 2000 Issued
Menu